Non-adherence to highly active antiretroviral therapy predicts progression to AIDS.
about
Emergence of drug resistance is associated with an increased risk of death among patients first starting HAARTHIV Treatment Adherence, Drug Resistance, Virologic Failure: Evolving ConceptsInterventions to improve adherence to antiretroviral therapy in children with HIV infectionComputer-based HIV adherence promotion interventions: a systematic review: Translation Behavioral MedicineThe impact of physician-nurse task shifting in primary care on the course of disease: a systematic reviewImpact of HIV-related stigma on treatment adherence: systematic review and meta-synthesisModeling antiretroviral drug responses for HIV-1 infected patients using differential equation modelsThe assessment of complementary and alternative medicine use among individuals with HIV: a systematic review and recommendations for future researchProfile of cabotegravir and its potential in the treatment and prevention of HIV-1 infection: evidence to dateAssociation between antiretroviral therapy adherence and employment status: systematic review and meta-analysisHigh-affinity recognition of HIV-1 frameshift-stimulating RNA alters frameshifting in vitro and interferes with HIV-1 infectivityAdherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitatorsInteractive "Video Doctor" counseling reduces drug and sexual risk behaviors among HIV-positive patients in diverse outpatient settingsSocial, structural and behavioral determinants of overall health status in a cohort of homeless and unstably housed HIV-infected menYoung HIV-infected children and their adult caregivers prefer tablets to syrup antiretroviral medications in AfricaA complex systems approach to evaluate HIV prevention in metropolitan areas: preliminary implications for combination intervention strategiesTimeliness of clinic attendance is a good predictor of virological response and resistance to antiretroviral drugs in HIV-infected patientsTrends in the population prevalence of people who inject drugs in US metropolitan areas 1992-2007HIV-1 pol diversity among female bar and hotel workers in Northern TanzaniaRational Design and Adaptive Management of Combination Therapies for Hepatitis C Virus InfectionEarly HAART Initiation May Not Reduce Actual Reproduction Number and Prevalence of MSM Infection: Perspectives from Coupled within- and between-Host Modelling Studies of Chinese MSM PopulationsShamba Maisha: Pilot agricultural intervention for food security and HIV health outcomes in Kenya: design, methods, baseline results and process evaluation of a cluster-randomized controlled trialPatient-Reported Barriers to Adherence to Antiretroviral Therapy: A Systematic Review and Meta-Analysis.Factors associated with adherence to antiretroviral therapy among adolescents living with HIV/AIDS in low- and middle-income countries: a systematic review.Visual analogue scale (VAS) measurement of antiretroviral adherence in people living with HIV (PLWH): a meta-analysis.Adherence to antiretroviral therapy in Nigeria: an overview of research studies and implications for policy and practice.Livelihood security and adherence to antiretroviral therapy in low and middle income settings: a systematic reviewAdherence support workers: a way to address human resource constraints in antiretroviral treatment programs in the public health setting in Zambia.Not all missed doses are the same: sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levels.Predictors of adherence to antiretroviral therapy among HIV-infected persons: a prospective study in Southwest Ethiopia.Good adherence to HAART and improved survival in a community HIV/AIDS treatment and care programme: the experience of The AIDS Support Organization (TASO), Kampala, Uganda.Lack of association between retrospectively collected pharmacy refill data and electronic drug monitoring of antiretroviral adherence.Supporting children to adhere to anti-retroviral therapy in urban Malawi: multi method insights.Antiretroviral therapy initiation before, during, or after pregnancy in HIV-1-infected women: maternal virologic, immunologic, and clinical response.The risk of virologic failure decreases with duration of HIV suppression, at greater than 50% adherence to antiretroviral therapy.Voices on adherence to ART in Ethiopia and Uganda: a matter of choice or simply not an option?Get+Connected: Development and Pilot Testing of an Intervention to Improve Computer and Internet Attitudes and Internet Use Among Women Living With HIV.The association between poor antiretroviral adherence and unsafe sex: differences by gender and sexual orientation and implications for scale-up of treatment as prevention.Site nurse-initiated adherence and symptom support telephone calls for HIV-positive individuals starting antiretroviral therapy, ACTG 5031: substudy of ACTG 384.Effect of directly observed therapy for highly active antiretroviral therapy on virologic, immunologic, and adherence outcomes: a meta-analysis and systematic review.
P2860
Q21563427-5751FB39-B4E0-48A1-B6F6-92D322C210C9Q22241321-B24ED86E-F0C4-4F42-96AE-73D44A50B999Q24234320-9D450732-B34E-4A01-A45D-088805695F9DQ26795553-1CCD140F-E979-4879-A90B-F950B7478D07Q26828894-CDDBE7A1-6E56-4257-ABF2-5A677C7B0CB8Q26830838-88638FE7-9440-4B57-91EB-7EBF146200CBQ27015861-1B716DE3-3234-43BC-BBD6-9793693CFFF1Q27022858-F5ED69B3-155C-40E9-9B92-F6AD947B21C3Q28079025-B6BCDF80-0EFB-4FB3-A46C-47C0294714C2Q28081677-DCED4BAC-0874-4A7D-9C95-2A2F08D30F6EQ28305122-7DBC18FD-79B9-4D8F-8CA8-F91085BFFCE6Q28469073-9C832F58-437D-4710-BC38-B0F336E050C8Q28472569-F64B530B-57E4-4B06-AA71-48780D662F73Q28482965-D5A49F15-BAC8-4E4B-9DD2-FB3905997CCEQ28483158-4B97D31F-6E16-45BC-8E4B-B411DB5E798DQ28483747-DC759857-2553-44D0-858E-9CE9877D8FF1Q28484929-A627F4A2-BDB9-4ECA-99CE-810F27A8A9F3Q28533642-07E02BCD-D195-4357-AE50-168DEBA95E41Q28540536-9141186B-6627-4DB5-A336-116344BCE0D1Q28545971-4F375D71-6471-44B2-9DB6-92E216610BD0Q28550445-F529A0F2-79E3-453C-8D05-5C6A30E091D6Q28647649-CC56DFC7-5A64-4989-98A1-A978D658598EQ30239741-4358E466-1658-4FAE-B64F-EA004AB5D6B8Q30371970-A59904F3-81C1-433D-86D6-B0BE9E89C574Q30391305-EE589130-9596-4285-BB91-107AFEE96F28Q30409638-27176CB8-1E6F-4FFF-B10B-578EEFCD2865Q31010456-180CB3D7-C7DE-4B40-8CB9-4AA6C117913AQ33336597-50D938EE-6F40-4EC9-8A73-47B56E49E47CQ33355997-9F8BA871-7AFC-4C80-BC6B-AD687D05B648Q33356236-DF73C733-77C5-4E89-9741-A09899399FAEQ33385849-C0DD6879-122A-41B6-919E-A26AA69779C7Q33393729-BC545180-B96D-4AF8-9036-0B1CF623AFEAQ33481996-B33012A1-E51C-4695-A3D9-21BC4302A5F5Q33501735-93F2DB1A-FA32-41FF-BB85-5CAD3D7A2E15Q33507274-4144A3F6-702D-4140-A376-BB9AE1D6B6C5Q33520008-8978944E-7789-4105-8D66-6BC962FC0B02Q33566363-4141BE6A-86BB-44EE-9CD9-7DAA9A9CEEFEQ33591117-92DCDCA1-D863-42CC-94A7-F3607207EA79Q33602445-6ABD32A2-711F-46F6-8E6D-54DB34893F8AQ33616453-382CAABC-0467-4729-8169-28BC751911D6
P2860
Non-adherence to highly active antiretroviral therapy predicts progression to AIDS.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Non-adherence to highly active antiretroviral therapy predicts progression to AIDS.
@en
Non-adherence to highly active antiretroviral therapy predicts progression to AIDS.
@nl
type
label
Non-adherence to highly active antiretroviral therapy predicts progression to AIDS.
@en
Non-adherence to highly active antiretroviral therapy predicts progression to AIDS.
@nl
prefLabel
Non-adherence to highly active antiretroviral therapy predicts progression to AIDS.
@en
Non-adherence to highly active antiretroviral therapy predicts progression to AIDS.
@nl
P2093
P1433
P1476
Non-adherence to highly active antiretroviral therapy predicts progression to AIDS.
@en
P2093
A R Zolopa
D R Bangsberg
E D Charlebois
M Roberston
P304
P356
10.1097/00002030-200106150-00015
P407
P577
2001-06-01T00:00:00Z